Overall survival (OS) results of phase III ARAMIS study of darolutamide added to androgen deprivation therapy (ADT) for non-metastatic castration-resistant prostate cancer (nmCRPC)

Laurence Krieger, Karim Fizazi, Neal Shore, Teuvo L. Tammela, Albertas Ulys, Egils Vjaters, Sergey Polyakov, Mindaugas Jievaltas, Murilo Luz, Boris Alekseev, Iris Kuss, Marie-Aude Le Berre, Oana Petrenciuc, Amir Snapir, Toni Sarapohja, Matthew R. Smith

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article numberabs 27
Pages (from-to)45-46
JournalAsia-Pacific Journal of Clinical Oncology
Volume16
Issue numberS9
Publication statusPublished - Nov 2020
Externally publishedYes
EventANZUP 2020 Mini Annual Scientific Meeting -
Duration: 29 Nov 202030 Nov 2020

Field of Science

  • 3.2 Clinical medicine

Publication Type

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this